This account will no longer be actively updated. We will continue to share Damon Runyon news and research updates on LinkedIn, Facebook, Instagram, Bluesky, and on

RT @AAnandappa: Thank you for this incredible honor! I am excited to continue our work on inflammatory signaling in RAS-mutated acute myelo….

Join millions who have switched to Grok.

RT @AlexandraRojek: Very honored to receive this award alongside such incredible colleagues @AAnandappa and @Charlie_S_Dai, and excited for….

RT @Charlie_S_Dai: Thank you for supporting our work! Hoping it leads to improved understandings in the perturbed epigenome of cancer and n….

RT @ldtimmerman: Sublime scenery. Smiling faces. Watch the highlight video of the Timmerman Traverse for @DamonRunyon for 90 seconds of joy….

Read more about the new Awardees and their projects:

@AAnandappa seeks to establish a role for RAS inhibitors in the treatment of acute myeloid leukemia (AML), an aggressive blood cancer, with the goal of designing combination therapies for patients with RAS-mutated AML.

@Charlie_S_Dai is investigating a new approach to treating certain breast and prostate cancers: by activating androgen receptors to disrupt the genes that these cancers rely on to grow.

@AlexandraRojek aims to uncover the differences between cellular therapies that confer long-lasting benefit and those that do not, with the goal of translating these findings to early phase trials of cellular therapies to treat lymphoma or melanoma.

Three clinicians with exceptional promise and novel approaches to fighting cancer have been named the 2025 recipients of the Damon Runyon Physician-Scientist Training Award.

RT @ldtimmerman: Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage (#349) to hear about the past, prese….

InVEST is designed to help close the gap between academic research and commercial funding, giving scientists the chance to move their ideas into the real world while providing a source of sustaining support for our high-impact award programs. Learn more:

InVEST’s strategic model:.🔬 Invest in scientists who have already gone through the rigorous Damon Runyon award selection process.💸 Provide early funding when it's hardest to get.🔁 Reinvest returns into our award programs to fund the next generation of cancer researchers.

Early-stage capital is one of the biggest barriers facing scientists who want to bring lab breakthroughs to industry. InVEST changes that, providing the first check to startups founded by Damon Runyon alumni.

We’ve launched a new seed investment program—InVEST—to fund biotech startups founded by our alumni scientists.🧵.

On Sunday we hosted our friends at the @illini4000 for breakfast at our office with current Damon Runyon Fellows Junhong Choi and Paul Klauser before they set off on their cross-country ride to raise money for cancer research. Follow along as they make their way to San Francisco!

Starting soon!.

This starts tomorrow! Mark your calendars and join us at all weekend to raise money for our brave and bold scientists. #ArvCon2025.

Singular Biotech.@TCGLifesciences . On behalf of all our scientists, thank you!.